287 related articles for article (PubMed ID: 29610117)
1. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma.
Shiraishi D; Fujiwara Y; Horlad H; Saito Y; Iriki T; Tsuboki J; Cheng P; Nakagata N; Mizuta H; Bekki H; Nakashima Y; Oda Y; Takeya M; Komohara Y
Cancer Res; 2018 Jun; 78(12):3255-3266. PubMed ID: 29610117
[TBL] [Abstract][Full Text] [Related]
2. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
3. M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer.
Aljabery F; Olsson H; Gimm O; Jahnson S; Shabo I
Urol Oncol; 2018 Apr; 36(4):159.e19-159.e26. PubMed ID: 29288002
[TBL] [Abstract][Full Text] [Related]
4. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
[TBL] [Abstract][Full Text] [Related]
5. CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrow.
Fischer-Riepe L; Daber N; Schulte-Schrepping J; Véras De Carvalho BC; Russo A; Pohlen M; Fischer J; Chasan AI; Wolf M; Ulas T; Glander S; Schulz C; Skryabin B; Wollbrink Dipl-Ing A; Steingraeber N; Stremmel C; Koehle M; Gärtner F; Vettorazzi S; Holzinger D; Gross J; Rosenbauer F; Stoll M; Niemann S; Tuckermann J; Schultze JL; Roth J; Barczyk-Kahlert K
J Allergy Clin Immunol; 2020 Nov; 146(5):1137-1151. PubMed ID: 32199911
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma.
Komohara Y; Niino D; Saito Y; Ohnishi K; Horlad H; Ohshima K; Takeya M
Cancer Sci; 2013 Jul; 104(7):945-51. PubMed ID: 23557330
[TBL] [Abstract][Full Text] [Related]
7. The significance of CD163-expressing macrophages in asthma.
Tokunaga Y; Imaoka H; Kaku Y; Kawayama T; Hoshino T
Ann Allergy Asthma Immunol; 2019 Sep; 123(3):263-270. PubMed ID: 31152786
[TBL] [Abstract][Full Text] [Related]
8. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
9. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
10. CD163: a specific marker of macrophages in paraffin-embedded tissue samples.
Lau SK; Chu PG; Weiss LM
Am J Clin Pathol; 2004 Nov; 122(5):794-801. PubMed ID: 15491976
[TBL] [Abstract][Full Text] [Related]
11. The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer.
Xu JY; Wang WS; Zhou J; Liu CY; Shi JL; Lu PH; Ding JL
Pancreas; 2019 Aug; 48(7):904-912. PubMed ID: 31268976
[TBL] [Abstract][Full Text] [Related]
12. The macrophage scavenger receptor CD163.
Fabriek BO; Dijkstra CD; van den Berg TK
Immunobiology; 2005; 210(2-4):153-60. PubMed ID: 16164022
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
[TBL] [Abstract][Full Text] [Related]
14. CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.
Guo L; Akahori H; Harari E; Smith SL; Polavarapu R; Karmali V; Otsuka F; Gannon RL; Braumann RE; Dickinson MH; Gupta A; Jenkins AL; Lipinski MJ; Kim J; Chhour P; de Vries PS; Jinnouchi H; Kutys R; Mori H; Kutyna MD; Torii S; Sakamoto A; Choi CU; Cheng Q; Grove ML; Sawan MA; Zhang Y; Cao Y; Kolodgie FD; Cormode DP; Arking DE; Boerwinkle E; Morrison AC; Erdmann J; Sotoodehnia N; Virmani R; Finn AV
J Clin Invest; 2018 Mar; 128(3):1106-1124. PubMed ID: 29457790
[TBL] [Abstract][Full Text] [Related]
15. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
[TBL] [Abstract][Full Text] [Related]
16. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
[TBL] [Abstract][Full Text] [Related]
17. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
[TBL] [Abstract][Full Text] [Related]
18. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
19. Generation of murine macrophage-derived cell lines expressing porcine CD163 that support porcine reproductive and respiratory syndrome virus infection.
Li L; Wu C; Hou G; Xue B; Xie S; Zhao Q; Nan Y; Zhang G; Zhou EM
BMC Biotechnol; 2017 Nov; 17(1):77. PubMed ID: 29121904
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions.
Alvarado-Vazquez PA; Bernal L; Paige CA; Grosick RL; Moracho Vilrriales C; Ferreira DW; Ulecia-Morón C; Romero-Sandoval EA
Immunobiology; 2017 Aug; 222(8-9):900-912. PubMed ID: 28545809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
